SMi's 1st Highly Potent Active Pharmaceutical Ingredients 2017 London, England, UK 22-23 May 2017

Description:
In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs).

With this continued development, SMi has been receptive to the steadily increasing market growth and have launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place 22nd – 23rd May in London, UK.

The conference programme has been produced to enable delegates to gain knowledgeable insight on how to develop highly potent APIs more efficiently, safely and more cost effectively than before. Whether your area of expertise is in process development, scale up, occupational safety or outsourcing, this two day conference is certain to equip you with a wealth of actionable insights.

Price:
Register by 31 Jan: GBP 1099
Register by 28 Feb: GBP 1299
Register by 31 Mar: GBP 1399
Standard Price: GBP 1499

Speakers: Pharmaceutical Sciences, Roche, AstraZeneca, Gedeon Richter Hungary, Boehringer Ingelheim, NuCana BioMed, Bristol-Myers Squibb, SKAN AG and many more!